Prof. Dr. Hasan Yazıcı
RheumatologyVerified
- 52+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Rheumatology
Antiphospholipid Syndrome Treatment in Turkey
Antiphospholipid syndrome is an autoimmune condition where the body mistakenly produces antibodies that increase the risk of abnormal blood clots. It commonly affects young and middle-aged adults, often coming to medical attention following recurrent deep vein thrombosis, unexplained strokes, or repeated pregnancy complications. Long-term management and individual treatment options depend on an in-depth specialist assessment. Compare hospitals in Turkey that treat Antiphospholipid Syndrome and get a free review of your medical records.
- Price from
- Price on request
- Clinics
- 1
Verified surgeons for Antiphospholipid Syndrome
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
About Antiphospholipid Syndrome
Antiphospholipid syndrome is an autoimmune condition where the body mistakenly produces antibodies that increase the risk of abnormal blood clots. It commonly affects young and middle-aged adults, often coming to medical attention following recurrent deep vein thrombosis, unexplained strokes, or repeated pregnancy complications. Long-term management and individual treatment options depend on an in-depth specialist assessment.
Specialty: Rheumatology
Best Clinics for Antiphospholipid Syndrome Treatment in Turkey
Frequently asked questions
The cost of treating Antiphospholipid Syndrome depends on the diagnosis and the treatment chosen. Doctors first review your medical records — free of charge — and you then receive an itemised quote.
Antiphospholipid Syndrome is treated by Rheumatology specialists. 1 clinic in Turkey on our platform offer this treatment.
What is Antiphospholipid Syndrome and What Are Its Symptoms?
Antiphospholipid syndrome (APS), sometimes called Hughes syndrome, is an autoimmune condition where the immune system mistakenly produces abnormal antibodies against normal blood proteins. These autoantibodies increase the tendency of blood platelets to clump, raising the risk of abnormal blood clots in veins and arteries.
APS can occur alone (primary APS) or alongside another autoimmune disorder such as lupus (secondary APS). Symptoms depend on the location of blood clots:
- Deep vein thrombosis (DVT): Swelling, warmth, redness, and aching pain, most often in the lower leg.
- Pulmonary embolism (PE): Sudden breathlessness, sharp chest pain when inhaling, and coughing.
- Arterial clots: Transient ischaemic attack (TIA) or stroke, causing sudden numbness, speech difficulty, or weakness, as well as heart complications.
- Obstetric complications: Recurrent miscarriages, second- or third-trimester foetal loss, or severe pre-eclampsia.
- Skin changes: A mottled, purplish, net-like rash on the limbs (livedo reticularis) and reduced platelet counts (thrombocytopenia).
How Antiphospholipid Syndrome is Diagnosed
Diagnosis requires meeting international criteria combining clinical events (such as a documented clot or pregnancy loss) with specific blood test results. A consultant in rheumatology oversees this evaluation.
Hospitals in Turkey carry out tests through their check-ups and diagnostics departments to establish an accurate profile:
- Lupus anticoagulant (LA): A functional blood test assessing clotting times in the laboratory.
- Anticardiolipin antibodies (aCL): Blood tests measuring IgG and IgM antibody levels.
- Anti-beta-2 glycoprotein I antibodies: An assay checking for antibodies linked to higher thrombotic risk.
- Repeat confirmatory testing: Criteria require at least one positive test confirmed on two occasions at least 12 weeks apart, ruling out transient antibodies from minor infections.
- Vascular imaging: Doppler ultrasound to check limb veins, echocardiography for heart valves, or CT scans if pulmonary clots are suspected.
International patients should bring past laboratory results showing antibody titres, hospital discharge summaries, pregnancy records, imaging reports, and current medication lists.
Treatment Options and Clinical Management
There is no cure for antiphospholipid syndrome. Care focuses on preventing new clots and managing pregnancy risks. Long-term treatment depends on individual risk profiles, and all decisions are made by the treating doctor after reviewing your test results.
| Option | Typically used when | Things to know |
|---|---|---|
| Low-dose aspirin | Positive antibodies without prior clots, or combined with other therapies in pregnancy. | Inhibits platelet aggregation; requires monitoring for bruising or stomach irritation. |
| Anticoagulants (warfarin or DOACs) | Patients with previous deep vein thrombosis or pulmonary embolism. | Warfarin requires regular INR monitoring; DOACs are generally avoided in high-risk triple-positive patients. |
| Low-molecular-weight heparin (LMWH) and aspirin | Pregnancy and post-partum care in women with obstetric APS. | Administered by daily subcutaneous injections; coordinated with gynaecology and IVF and fertility specialists. |
| Immunoglobulins or plasma exchange | Catastrophic antiphospholipid syndrome (CAPS) or severe refractory cases. | Hospital-based therapies that rapidly suppress acute antibody activity across microvascular beds. |
For secondary APS, managing the underlying rheumatological condition is equally important. When heart valve complications arise, evaluation alongside cardiac surgery teams may be advised.
Planning Antiphospholipid Syndrome Treatment in Turkey
Planning medical travel for APS begins with a remote evaluation of your existing medical files and blood tests. This allows Turkish specialists to determine which confirmatory tests or specialty consultations are necessary before you travel.
An in-person diagnostic trip typically lasts 4 to 7 days, allowing time for specialist consultations, detailed coagulation testing, and vascular scans. Because international guidelines require a 12-week interval between repeat blood tests to confirm persistent antibodies, new diagnoses may involve initial testing in Turkey with follow-up at home, or a planned return trip.
Anticoagulation requires consistent lifelong monitoring. Before departure, your hospital provides an English-language medical report detailing your diagnosis, target INR range (if taking warfarin), medication schedule, and instructions for your local haematologist or general practitioner.
When Travel is Not Advisable and Emergency Warning Signs
Travel is not advisable for everyone. Long flights involve extended immobility, which increases clotting risks. Do not travel if you experienced a clot within the past 4 to 6 weeks, if your anticoagulation is unstable, or if you have active bleeding.
Seek immediate local emergency care rather than travelling if you notice these warning signs:
- Sudden breathlessness, chest pain when breathing in, or coughing blood.
- Pain, severe swelling, redness, or warmth in an arm or leg.
- Sudden weakness, facial drooping, speech difficulty, or vision changes.
- Severe, persistent headache or sudden loss of balance.
- Unexplained bruising, bleeding gums, or blood in the urine or stool.
Frequently asked questions
There is currently no permanent cure for antiphospholipid syndrome. However, the condition can be managed effectively with long-term anticoagulant or antiplatelet medications. With careful medical supervision, individualised treatment plans help prevent recurrent blood clots, reduce cardiovascular complications, and support successful pregnancies. Ongoing monitoring by a specialist haematologist or rheumatologist is essential to adjust medication dosages and maintain therapeutic levels safely over your lifetime.
Flying is possible for many people with stable antiphospholipid syndrome, but long-distance travel carries increased clotting risks. You should always obtain clearance from your doctor before booking travel. Preventative measures typically include wearing graduated compression stockings, staying well hydrated, regularly exercising your calf muscles during the journey, and ensuring your anticoagulant therapy is stable. Patients with recent or unmanaged clots should avoid flying until cleared by their specialist.
Primary antiphospholipid syndrome occurs independently in individuals with no other autoimmune disorders. Secondary antiphospholipid syndrome develops in people who already have an underlying autoimmune condition, most commonly systemic lupus erythematosus or rheumatoid arthritis. While both forms carry similar risks of blood clots and require anticoagulant therapy, secondary APS requires additional coordinated management to control the underlying rheumatological disease and reduce systemic inflammation.
Yes, many women with antiphospholipid syndrome carry successful pregnancies to term with specialist medical care. Management typically combines low-dose aspirin and daily low-molecular-weight heparin injections initiated early in pregnancy and continued for several weeks post-partum. Close multidisciplinary monitoring by maternal-foetal medicine experts and rheumatologists helps manage blood flow, prevent placental thrombosis, and minimise the risks of recurrent miscarriage or pre-eclampsia.
Antiphospholipid antibodies can temporarily appear in the blood following minor viral or bacterial infections without causing a chronic autoimmune condition. International diagnostic guidelines therefore mandate that positive tests—such as lupus anticoagulant, anticardiolipin, or anti-beta-2 glycoprotein I—must be confirmed on a second blood sample taken at least 12 weeks later. This confirms antibody persistence before a lifelong diagnosis and long-term anticoagulation therapy are initiated.